NCT06813144Not yet recruiting
Effectiveness of Respiratory Muscle Training with a Mobile Application After Lobectomy
Evaluation of the Effectiveness of Respiratory Muscle Training with a Mobile Application in the Early Postoperative Period After Lobectomy
Source: ClinicalTrials.gov · Last updated 6 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
It has been observed that there are negative effects on respiratory muscle strength following lobectomy. This has led to the necessity of respiratory muscle training to mitigate these adverse effects. Most studies conducted so far focus on the late postoperative period, and there are only a few studies evaluating the effectiveness of early postoperative inspiratory muscle training (IMT). It is believed that this method could be useful for facilitating patient follow-up and increasing patient motivation through visual feedback.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- First submitted
- 22 Jan 2025
- Start date
- 1 Mar 2025
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- Hacettepe University
- Diseases
- Lung cancer
- NCT number
- NCT06813144
What you commit to
- Study type: Interventional
- Planned participants: 45
- From 1 Mar 2025 to the primary completion date, 1 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having undergone any surgery related to the thoracic wall,
Other illness
- Having diseases that will affect respiratory parameters such as severe heart failure, severe chronic obstructive pulmonary disease (COPD).
Other
- Having any orthopedic or neurological problem that prevents walking,
Who the study is looking for
- Volunteering to participate in the study,
- Being clinically stable,
- Being a lung cancer patient with a planned lobectomy with VATS,
- Being between the ages of 18-65,
- Being able to cooperate with the tests to be performed.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hacettepe University Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.